Featured Insights
September 8, 2026
Newsletter
An update on legal and regulatory developments for UK public companies.
September 8, 2026
Newsletter
Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, Medicare, and state law.
September 4, 2026
Blog
The proposal would expand the conditions for maintaining Section 501(c)(3) status and eliminate existing exceptions for certain race-conscious programs.